Articles

The goal of The Practice Solution Magazine is to provide practice owners with practice management information that will assist them in achieving success.

WASHINGTON /PRNewswire-FirstCall/ — Halozyme Therapeutics, Inc. a development stage biopharmaceutical company focused on the development and commercialization of recombinant human enzymes, announced that results from new preclinical studies with Halozyme’s recombinant...